Evaluation of AppleX™ Apple Extract on Anti-Inflammatory and Healthy Aging Effects
Key claim: A placebo-controlled clinical trial is testing whether daily AppleX™ apple extract lowers hsCRP and improves fatigue, joint comfort, and biological/epigenetic aging metrics in adults aged 45–70 with low-grade inflammation.
Abstract
The goal of this clinical trial is to learn if AppleX™ Apple Extract can help lower systemic inflammation in adults aged 45-70 with signs of low-grade inflammation. It will also look at the extract’s effects on fatigue, joint comfort, and biological aging metrics.
The main questions it aims to answer are:
- Does taking AppleX™ Apple Extract daily lower high-sensitivity C-reactive protein (hsCRP) levels, a key marker of inflammation in the blood?
- Does AppleX™ Apple Extract improve participant-reported fatigue and joint comfort?
- Does the extract slow down biological or epigenetic aging metrics compared to a placebo?
Researchers will compare AppleX™ Apple Extract to a placebo (a look-alike capsule that contains no active ingredients) to see if the apple extract has a measurable anti-inflammatory and healthy aging effect.
Why this matters
A placebo-controlled clinical trial is testing whether daily AppleX™ apple extract lowers hsCRP and improves fatigue, joint comfort, and biological/epigenetic aging metrics in adults aged 45–70 with low-grade inflammation.